Israeli Beta-O2, a company just coming out of stealth mode, announced that its ßAir bio-artificial pancreas will be put through a clinical trial thanks to a grant from the Juvenile Diabetes Research Foundation (JDRF). The initial trial will involve eight patients at the Uppsala University Hospital in Sweden who will use the new device for approximately two years to assess the safety, survival, and function of implanted pancreatic endocrine cells.
Hey, check out all the engineering jobs. Post your resume today!
